U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07161583) titled 'Advanta VXT and Flixene PMCF Registry' on Aug. 12.
Brief Summary: The purpose of the registry is to evaluate the long-term safety and performance of Advanta VXT and Flixene vascular grafts for repair or replacement of peripheral arteries. This registry is also intended to provide further data on the clinical usefulness of the Advanta VXT and Flixene vascular grafts.
Study Start Date: Sept., 2025
Study Type: OBSERVATIONAL
Condition:
Peripheral Arterial Disease
Intervention:
DEVICE: Advanta VXT Vascular Graft
The Advanta VXT graft is a two (2)-layer graft employing a single layer ePTFE graft, which is then wrapped with an addit...